Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Annals of Hematology|November 1, 1993
Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distributionM B Vidriales, A Orfao, M C López-Berges, et al.
Leukemia|December 1, 1993
Expression of NK and lymphoid-associated antigens in blast cells of acute myeloblastic leukemiaM B Vidriales, A Orfao, M González, et al.
Cytometry|May 14, 1999
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemiaA Martínez, J F San Miguel, M B Vidriales, et al.
Cytometry|March 15, 1995
DNA aneuploidy in acute myeloblastic leukemia is associated with a high expression of lymphoid markersM B Vidriales, A Orfao, M C López-Berges, et al.
Blood|September 6, 2001
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratificationJ F San Miguel, M B Vidriales, C López-Berges, et al.
Blood|October 6, 1997
Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patientsJ F San Miguel, A Martínez, A Macedo, et al.
Seminars in Oncology|April 30, 2003
Immunophenotypic analysis of Waldenstrom's macroglobulinemiaJ F San Miguel, M B Vidriales, E Ocio, et al.
Leukemia|September 6, 2012
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocolsT Kalina, J Flores-Montero, V H J van der Velden, et al.
Leukemia|July 18, 2013
Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometryN Puig, M E Sarasquete, A Balanzategui, et al.
Leukemia|November 4, 2017
Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trialsP Arana, B Paiva, M-T Cedena, et al.
Pageof 3